Reinhardt’s move, which includes serving on the company’s executive leadership team, goes into effect on June 10, 2024. His responsibilities include leading SeaSpine, the company’s global spine and biologics business created through a massive merger last year.
It marks the latest significant leadership move at the Lewisville, Texas-based company. Last fall, the company terminated a trio of executives with cause. Orthofix cut ties with CEO Keith Valentine, CFO John Bostjancic and chief legal officer Patrick Keran following an investigation.
The company then picked former LimaCorporate CEO Massimo Calafiore as its next CEO in November. In January, Julie Andrews took over as CFO, followed by the appointment of Andres Cedron as chief legal officer last month.
Reinhardt joins the company as global spine president with more than 30 years of experience in medtech and pharmaceuticals, including 17 years at Johnson & Johnson.
More about new Orthofix executive Max Reinhardt
Reinhardt had significant experience in roles of increasing responsibility at Johnson & Johnson. In 2012, he took over as worldwide president of DePuy Synthes Spine. Other roles included VP of marketing for U.S. orthopedics and global franchise leader and worldwide president of joint reconstruction, sports medicine and power tools at DePuy.
“Max brings strong leadership and a proven track record of success to our global spine business,” said Calafiore. “He brings a wealth of experience in driving innovation while continually executing focused strategies to drive commercial success. I look forward to the guidance and expertise he will bring to our organization as we continue to accelerate and position Orthofix as one of the leading spine companies in the market.”
Before his time at Johnson & Johnson, Reinhardt held senior leadership positions at Steris and Olympus in Europe. Most recently, he served in different leadership posts for Pacira Biosciences, which develops non-opioid pain management solutions.
“I am delighted to have the opportunity to lead the talented spine team at Orthofix as we continue to innovate and introduce differentiated products and procedurally integrated solutions to the market to solve complex spine problems,” said Reinhardt. “I believe the company has a strong foundation and is well positioned for growth in the years ahead. I look forward to working with our dedicated team members to deliver new product solutions and provide exceptional support for our surgeon customers and their patients.”
